Howard Horn
2021
In 2021, Howard Horn earned a total compensation of $5.1M as Chief Financial Officer at Vir Biotechnology, a 214% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $259,560 |
|---|---|
| Option Awards | $2,731,950 |
| Salary | $461,250 |
| Stock Awards | $1,684,500 |
| Other | $11,600 |
| Total | $5,148,860 |
Horn received $2.7M in option awards, accounting for 53% of the total pay in 2021.
Horn also received $259.6K in non-equity incentive plan, $461.3K in salary, $1.7M in stock awards and $11.6K in other compensation.
Rankings
In 2021, Howard Horn's compensation ranked 2,527th out of 12,415 executives tracked by ExecPay. In other words, Horn earned more than 79.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,527 out of 12,415 | 80th |
Division Manufacturing | 1,006 out of 5,508 | 82nd |
Major group Chemicals And Allied Products | 384 out of 2,378 | 84th |
Industry group Drugs | 335 out of 2,099 | 84th |
Industry Biological Products, Except Diagnostic Substances | 101 out of 449 | 78th |
Source: SEC filing on April 7, 2022.
Horn's colleagues
We found four more compensation records of executives who worked with Howard Horn at Vir Biotechnology in 2021.